MASCC index
Identifies adults with cancer and febrile neutropenia at low risk of serious complications who may be candidates for oral antibiotics and outpatient care.
Calculate with transparency
Check the population, units and version. The result shows the formula or classification; it does not make an automatic treatment decision.
Preparing the form…
- Check the method
- Enter the data
- Check the result
Method · Limits of application
MASCC/Klastersky 2000: 7 domains, total 0–26, cutoff ≥21; ASCO/IDSA 2018 context
MASCC ≥21 indicates a lower risk of complications but does not, on its own, authorize discharge, oral antibiotics or outpatient management. In the ASCO/IDSA 2018 context, selection depends on clinical assessment, stability, comorbidities, ability to attend return visits, a caregiver at home, and access to a telephone and transport. Candidates for outpatient management must be observed for at least 4 hours before discharge and require follow-up. The hypotension criterion in this implementation follows the original 2000 variable: SBP <90 mmHg.
Conditions of use
Check the population, units, inclusion and exclusion criteria, and version in the original source. A result alone does not establish a diagnosis, discharge decision or prescription.
Documented parameters
- Burden of illness (symptoms of the febrile episode)
- Hypotension (systolic blood pressure < 90 mmHg)
- Active COPD
- Cancer type
- Dehydration requiring intravenous fluids
- Where fever began
- Age
3/3 reference cases checked. Numerical tests are not clinical validation.
Relationship with cancer research
Specific oncological application
A complication index in febrile neutropenia in adults with cancer. Eligibility, signs of severity and management decisions require a specific clinical assessment.
Applications: Adverse effects and safety